OCUGEN, INC. Operating Lease, Liability, Noncurrent
OCUGEN, INC. (OCGN) had Operating Lease, Liability, Noncurrent of $3.04 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Noncurrent $3.04M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $3.25M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $3.49M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $3.71M.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $3.04M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $3.25M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $3.49M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $3.71M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $3.94M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $3.42M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $3.31M 10-K · filed 2026-03-04 | |
| 2024-09-30 | $3.42M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $3.55M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $3.41M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $3.57M 10-K · filed 2025-03-05 | |
| 2023-09-30 | $3.16M 10-K · filed 2024-04-16 | |
| 2023-06-30 | $3.31M 10-K · filed 2024-04-16 | |
| 2023-03-31 | $3.45M 10-K · filed 2024-04-16 | |
| 2022-12-31 | $3.59M 10-K · filed 2024-04-16 | |
| 2022-09-30 | $3.76M 10-K · filed 2024-04-16 | |
| 2022-06-30 | $3.89M 10-K · filed 2024-04-16 | |
| 2022-03-31 | $1.18M 10-K · filed 2024-04-16 | |
| 2021-12-31 | $1.23M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $1.28M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $1.33M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $1.38M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $389.00K 10-K · filed 2022-02-28 | $389.32K 10-K · filed 2021-03-19 |
| 2020-09-30 | $42.75K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $75.58K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $117.14K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $163.20K 10-K · filed 2021-03-19 | |
| 2019-09-30 | $223.85K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $267.19K 8-K/A · filed 2019-10-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |